Esophagogastric Cancer Withdrawn Phase 2 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0047780 (Esophagogastric Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02296671Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic MarkersTreatment